Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Angiongenesis Inhibitors and Stimulators market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Angiongenesis Inhibitors and Stimulatorsmarket, defines the market attractiveness level of Angiongenesis Inhibitors and Stimulators market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Angiongenesis Inhibitors and Stimulators industry, describes the types of Angiongenesis Inhibitors and Stimulators market, the applications of major players and the market size, and deeply analyzes the current situation of the global Angiongenesis Inhibitors and Stimulators market and the development prospects and opportunities of Angiongenesis Inhibitors and Stimulators industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Angiongenesis Inhibitors and Stimulators market in Chapter 13.
By Player:
AstraZeneca
Genentech
Pfizer
Eyetech
Chugai Pharmaceutical
F Hoffman-La Roche
Abbott Laboratories
Novartis
Amgen
EntreMed
Adnexus Therapeutics
By Type:
Sprouting Angiogenesis
Intussusceptive Angiogenesis
By End-User:
Hospitals
Clinics
Other
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Angiongenesis Inhibitors and Stimulators Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Angiongenesis Inhibitors and Stimulators Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Angiongenesis Inhibitors and Stimulators Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Angiongenesis Inhibitors and Stimulators Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Angiongenesis Inhibitors and Stimulators Market Analysis and Outlook to 2022
-
7.1 Global Angiongenesis Inhibitors and Stimulators Consumption (2017-2022)
-
7.2 United States Angiongenesis Inhibitors and Stimulators Consumption (2017-2022)
-
7.3 Europe Angiongenesis Inhibitors and Stimulators Consumption (2017-2022)
-
7.4 China Angiongenesis Inhibitors and Stimulators Consumption (2017-2022)
-
7.5 Japan Angiongenesis Inhibitors and Stimulators Consumption (2017-2022)
-
7.6 India Angiongenesis Inhibitors and Stimulators Consumption (2017-2022)
-
7.7 South Korea Angiongenesis Inhibitors and Stimulators Consumption (2017-2022)
8 Region and Country-wise Angiongenesis Inhibitors and Stimulators Market Analysis and Outlook to 2028
-
8.1 Global Angiongenesis Inhibitors and Stimulators Consumption Forecast (2022-2028)
-
8.2 United States Angiongenesis Inhibitors and Stimulators Consumption Forecast (2022-2028)
-
8.3 Europe Angiongenesis Inhibitors and Stimulators Consumption Forecast (2022-2028)
-
8.4 China Angiongenesis Inhibitors and Stimulators Consumption Forecast (2022-2028)
-
8.5 Japan Angiongenesis Inhibitors and Stimulators Consumption Forecast (2022-2028)
-
8.6 India Angiongenesis Inhibitors and Stimulators Consumption Forecast (2022-2028)
-
8.7 South Korea Angiongenesis Inhibitors and Stimulators Consumption Forecast (2022-2028)
9 Global Angiongenesis Inhibitors and Stimulators Market Outlook by Types and Applications to 2022
-
9.1 Global Angiongenesis Inhibitors and Stimulators Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Sprouting Angiogenesis Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Intussusceptive Angiogenesis Consumption and Growth Rate (2017-2022)
-
9.2 Global Angiongenesis Inhibitors and Stimulators Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospitals Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Clinics Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Other Consumption and Growth Rate (2017-2022)
10 Global Angiongenesis Inhibitors and Stimulators Market Outlook by Types and Applications to 2028
-
10.1 Global Angiongenesis Inhibitors and Stimulators Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Sprouting Angiogenesis Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Intussusceptive Angiogenesis Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Angiongenesis Inhibitors and Stimulators Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hospitals Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Clinics Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Other Consumption Forecast and Growth Rate (2022-2028)
11 Global Angiongenesis Inhibitors and Stimulators Import and Export Analysis (Top 5 Countries)
-
11.1 Global Angiongenesis Inhibitors and Stimulators Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Angiongenesis Inhibitors and Stimulators Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Angiongenesis Inhibitors and Stimulators Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Angiongenesis Inhibitors and Stimulators Market Competitive Analysis
-
14.1 AstraZeneca
-
14.1.1 AstraZeneca Company Details
-
14.1.2 AstraZeneca Angiongenesis Inhibitors and Stimulators Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 AstraZeneca Angiongenesis Inhibitors and Stimulators Product and Service
-
14.2 Genentech
-
14.2.1 Genentech Company Details
-
14.2.2 Genentech Angiongenesis Inhibitors and Stimulators Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Genentech Angiongenesis Inhibitors and Stimulators Product and Service
-
14.3 Pfizer
-
14.3.1 Pfizer Company Details
-
14.3.2 Pfizer Angiongenesis Inhibitors and Stimulators Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Pfizer Angiongenesis Inhibitors and Stimulators Product and Service
-
14.4 Eyetech
-
14.4.1 Eyetech Company Details
-
14.4.2 Eyetech Angiongenesis Inhibitors and Stimulators Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Eyetech Angiongenesis Inhibitors and Stimulators Product and Service
-
14.5 Chugai Pharmaceutical
-
14.5.1 Chugai Pharmaceutical Company Details
-
14.5.2 Chugai Pharmaceutical Angiongenesis Inhibitors and Stimulators Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Chugai Pharmaceutical Angiongenesis Inhibitors and Stimulators Product and Service
-
14.6 F Hoffman-La Roche
-
14.6.1 F Hoffman-La Roche Company Details
-
14.6.2 F Hoffman-La Roche Angiongenesis Inhibitors and Stimulators Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 F Hoffman-La Roche Angiongenesis Inhibitors and Stimulators Product and Service
-
14.7 Abbott Laboratories
-
14.7.1 Abbott Laboratories Company Details
-
14.7.2 Abbott Laboratories Angiongenesis Inhibitors and Stimulators Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Abbott Laboratories Angiongenesis Inhibitors and Stimulators Product and Service
-
14.8 Novartis
-
14.8.1 Novartis Company Details
-
14.8.2 Novartis Angiongenesis Inhibitors and Stimulators Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Novartis Angiongenesis Inhibitors and Stimulators Product and Service
-
14.9 Amgen
-
14.9.1 Amgen Company Details
-
14.9.2 Amgen Angiongenesis Inhibitors and Stimulators Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Amgen Angiongenesis Inhibitors and Stimulators Product and Service
-
14.10 EntreMed
-
14.10.1 EntreMed Company Details
-
14.10.2 EntreMed Angiongenesis Inhibitors and Stimulators Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 EntreMed Angiongenesis Inhibitors and Stimulators Product and Service
-
14.11 Adnexus Therapeutics
-
14.11.1 Adnexus Therapeutics Company Details
-
14.11.2 Adnexus Therapeutics Angiongenesis Inhibitors and Stimulators Sales, Price, Value and Gross Profit (2017-2022)
-
14.11.3 Adnexus Therapeutics Angiongenesis Inhibitors and Stimulators Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Angiongenesis Inhibitors and Stimulators
-
Figure Angiongenesis Inhibitors and Stimulators Picture
-
Table Global Angiongenesis Inhibitors and Stimulators Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Angiongenesis Inhibitors and Stimulators Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Angiongenesis Inhibitors and Stimulators Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Angiongenesis Inhibitors and Stimulators Consumption by Country (2017-2022)
-
Figure United States Angiongenesis Inhibitors and Stimulators Consumption and Growth Rate (2017-2022)
-
Table Europe Angiongenesis Inhibitors and Stimulators Consumption and Growth Rate (2017-2022)
-
Figure China Angiongenesis Inhibitors and Stimulators Consumption and Growth Rate (2017-2022)
-
Figure Japan Angiongenesis Inhibitors and Stimulators Consumption and Growth Rate (2017-2022)
-
Figure India Angiongenesis Inhibitors and Stimulators Consumption and Growth Rate (2017-2022)
-
Figure South Korea Angiongenesis Inhibitors and Stimulators Consumption and Growth Rate (2017-2022)
-
Figure Global Angiongenesis Inhibitors and Stimulators Consumption Forecast by Country (2022-2028)
-
Figure United States Angiongenesis Inhibitors and Stimulators Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Angiongenesis Inhibitors and Stimulators Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Angiongenesis Inhibitors and Stimulators Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Angiongenesis Inhibitors and Stimulators Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Angiongenesis Inhibitors and Stimulators Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Angiongenesis Inhibitors and Stimulators Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Sprouting Angiogenesis Consumption and Growth Rate (2017-2022)
-
Figure Global Intussusceptive Angiogenesis Consumption and Growth Rate (2017-2022)
-
Figure Global Hospitals Consumption and Growth Rate (2017-2022)
-
Figure Global Clinics Consumption and Growth Rate (2017-2022)
-
Figure Global Other Consumption and Growth Rate (2017-2022)
-
Figure Global Sprouting Angiogenesis Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Intussusceptive Angiogenesis Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospitals Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Clinics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Angiongenesis Inhibitors and Stimulators Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Angiongenesis Inhibitors and Stimulators Export by Region (Top 5 Countries) (2017-2028)
-
Table AstraZeneca (Foundation Year, Company Profile and etc.)
-
Table AstraZeneca Angiongenesis Inhibitors and Stimulators Sales, Price, Value and Gross Profit (2017-2022)
-
Table AstraZeneca Angiongenesis Inhibitors and Stimulators Product and Service
-
Table Genentech (Foundation Year, Company Profile and etc.)
-
Table Genentech Angiongenesis Inhibitors and Stimulators Sales, Price, Value and Gross Profit (2017-2022)
-
Table Genentech Angiongenesis Inhibitors and Stimulators Product and Service
-
Table Pfizer (Foundation Year, Company Profile and etc.)
-
Table Pfizer Angiongenesis Inhibitors and Stimulators Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Angiongenesis Inhibitors and Stimulators Product and Service
-
Table Eyetech (Foundation Year, Company Profile and etc.)
-
Table Eyetech Angiongenesis Inhibitors and Stimulators Sales, Price, Value and Gross Profit (2017-2022)
-
Table Eyetech Angiongenesis Inhibitors and Stimulators Product and Service
-
Table Chugai Pharmaceutical (Foundation Year, Company Profile and etc.)
-
Table Chugai Pharmaceutical Angiongenesis Inhibitors and Stimulators Sales, Price, Value and Gross Profit (2017-2022)
-
Table Chugai Pharmaceutical Angiongenesis Inhibitors and Stimulators Product and Service
-
Table F Hoffman-La Roche (Foundation Year, Company Profile and etc.)
-
Table F Hoffman-La Roche Angiongenesis Inhibitors and Stimulators Sales, Price, Value and Gross Profit (2017-2022)
-
Table F Hoffman-La Roche Angiongenesis Inhibitors and Stimulators Product and Service
-
Table Abbott Laboratories (Foundation Year, Company Profile and etc.)
-
Table Abbott Laboratories Angiongenesis Inhibitors and Stimulators Sales, Price, Value and Gross Profit (2017-2022)
-
Table Abbott Laboratories Angiongenesis Inhibitors and Stimulators Product and Service
-
Table Novartis (Foundation Year, Company Profile and etc.)
-
Table Novartis Angiongenesis Inhibitors and Stimulators Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis Angiongenesis Inhibitors and Stimulators Product and Service
-
Table Amgen (Foundation Year, Company Profile and etc.)
-
Table Amgen Angiongenesis Inhibitors and Stimulators Sales, Price, Value and Gross Profit (2017-2022)
-
Table Amgen Angiongenesis Inhibitors and Stimulators Product and Service
-
Table EntreMed (Foundation Year, Company Profile and etc.)
-
Table EntreMed Angiongenesis Inhibitors and Stimulators Sales, Price, Value and Gross Profit (2017-2022)
-
Table EntreMed Angiongenesis Inhibitors and Stimulators Product and Service
-
Table Adnexus Therapeutics (Foundation Year, Company Profile and etc.)
-
Table Adnexus Therapeutics Angiongenesis Inhibitors and Stimulators Sales, Price, Value and Gross Profit (2017-2022)
-
Table Adnexus Therapeutics Angiongenesis Inhibitors and Stimulators Product and Service
-
